
Overview
Background
Christine graduated with a Bachelor of Pharmacy degree (honours class 1) from the University of Queensland in 1996.
She registered as a pharmacist in Australia in 1997 and in the United Kingdom in 2003 and has worked at the Redlands, Princess Alexandra and Wesley Hospitals in Brisbane and the Western Infirmary in Glasgow. In 2002 she was awarded a PhD from the University of Queensland, with a thesis focusing on improving usage of the immunosuppressant agent tacrolimus in solid organ transplant recipients.
In 2004 she was the recipient of a National Health and Medical Research Council (NHMRC) Neil Hamilton Fairley fellowship. This award enabled her to training overseas in the field of Pharmacometrics within the Department of Medicine and Therapeutics at the University of Glasgow (Scotland) and the Department of Pharmaceutical Biosciences at Uppsala University (Sweden).
On her return to Brisbane, Christine was the recipient of a Lions Medical Research Fellowship and was the chief investigator on a three year NHMRC Project Grant. She has also been a team member on an Amgen-Transplant Society of Australia and New Zealand Research Grant and a Cellcept Australia Research Grant. Over her research career Christine has attracted grants and awards totaling more than 2 million AUD from various funding agencies.
Research Interests
Christine has a wide range of interests in the fields of Quality Use of Medicine and Pharmacometrics. Her work to date has primarily been directed towards optimising usage of immunosuppressant drugs in solid organ transplant recipients and antibiotics in patients with life-threatening infections.
Christine has published over 75 peer reviewed papers and 90 conference abstracts on these topics. Her publications have been cited on more than 3200 occasions, with twelve cited more than 50 times.
Christine has successfully supervised to completion fourteen higher research degree students and enjoys helping students meet their career goals.
Christine’s current projects include:
- Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
- Comparing the efficacy and safety of continuous versus intermittent administration of beta-lactams in critically ill patients
- Examining the relationship between immunosuppression and non-melanoma skin cancer in renal transplant recipients
- Improving individualisation of immunosuppressant therapy in adult kidney transplant recipients
- Improving gentamycin dosing in paediatric oncology patients
- Examining tobramycin monitoring in cystic fibrosis patients in Australia and the United Kingdom
- Investigating the relationship between prednisolone exposure and drug-related toxicity in paediatric and adult kidney transplant recipients
- Comparing different therapeutic drug monitoring methods for dosage adjustment of once daily intravenous tobramycin treatment in children with cystic fibrosis
Projects currently available for interested research higher degree students include:
- Dose optimisation of busulfan in paediatric bone marrow transplant recipients
- Investigating the relationship between immunosupressant exposure and drug-related toxicity in transplant recipients
- Examining Bayesian forecasting methods to predict immunosuppressant exposure
- Examining the international use of immunosuppressant and anti-rheumatic drugs
- Examining the influence of plasma exchange on immunosuppressant drug exposure
Christine invites potential honours and post-graduate students to contact her via email to discuss research opportunities.
Teaching interests
Co-ordinates:
- PHRM3052- Biological Fate of Drugs
Teaches in:
- PHRM3052- Biological Fate of Drugs
- PHRM3011- Quality Use of Medicines
Availability
- Dr Christine Staatz is:
- Available for supervision
Fields of research
Qualifications
- Bachelor, The University of Queensland
- Bachelor (Honours) of Pharmacy, The University of Queensland
- Doctor of Philosophy, The University of Queensland
Works
Search Professor Christine Staatz’s works on UQ eSpace
2014
Conference Publication
Comparing dosage adjustment methods for once daily tobramycin in children with cystic fibrosis
Hennig, Stefanie, Teo, Beverly, Stiller, Franziska and Staatz, Christine (2014). Comparing dosage adjustment methods for once daily tobramycin in children with cystic fibrosis. PAGANZ 2014: 16th Annual Population Approach Group in Australia and New Zealand Meeting, Dunedin, New Zealand, 29-31 January, 2014. Auckland Central, Auckland, NZ: Population Approach Group of Australia and New Zealand (PAGANZ ).
2014
Conference Publication
A survey of intravenous tobramycin monitoring and dosage adjustment practice in cystic fibrosis patients in Australia and the United Kingdom
Staatz, C. E., Paviour, S. and Hennig, S. (2014). A survey of intravenous tobramycin monitoring and dosage adjustment practice in cystic fibrosis patients in Australia and the United Kingdom. Population Approach Group in Europe conference, Alicante, Spain, June 2014.
2014
Conference Publication
Cyclosporine and tacrolimus patients have similar dose adjusted prednisolone exposure
Bergmann, TB, Isbel, NM, Barraclough, KA, Campbell, SB, McWhinney, BC and Staatz, CE (2014). Cyclosporine and tacrolimus patients have similar dose adjusted prednisolone exposure. Annual meeting of the Danish Society of Pharmacology conference, Odense, Denmark, Janurary.
2014
Conference Publication
Bcl-Xl and McL1 Expression in Non Melanoma Skin Cancers in Renal Transplant Recipients
Burke, Michael, Morais, Christudas, Soyer, Peter, Sinnya, Sudipta, Winterford, Clay, Oliver, Kimberley, Lambie, Duncan, Staatz, Christine, Carroll, Robert, Campbell, Scott and Isbel, Nicole (2014). Bcl-Xl and McL1 Expression in Non Melanoma Skin Cancers in Renal Transplant Recipients. 51st Congress of the European Renal Association(ERA)/European Dialysis and Transplant Association (EDTA), Amsterdam Netherlands, 31 May- 03 June 2014. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ndt/gfu161
2014
Journal Article
Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling
Størset, Elisabet, Holford, Nick, Hennig, Stefanie, Bergmann, Troels K., Bremer, Stein, Bergan, Sara, Åsberg, Anders, Midtvedt, Karsten and Staatz, Christine E. (2014). Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling. British Journal of Clinical Pharmacology, 78 (3), 509-523. doi: 10.1111/bcp.12361
2014
Conference Publication
Evaluation of dosing strategies to achieve targeted tacrolimus exposure after adult kidney transplantation
Størset, E., Holford, N., Hennig, S., Bergmann, T. K., Bergan, S., Bremer, S., Åsberg, A., Midtvedt, K. and Staatz, C. E. (2014). Evaluation of dosing strategies to achieve targeted tacrolimus exposure after adult kidney transplantation. Population Approach Group in Europe Conference, Alicante, Spain, June 2014.
2014
Book Chapter
Pharmacokinetic, pharmacogenetic and pharmacodynamic monitoring of tacrolimus, mycophenolate and oral corticosteroids in adult kidney transplantation
Barraclough, K. A., Staatz, C. E. and Isbel, N. M. (2014). Pharmacokinetic, pharmacogenetic and pharmacodynamic monitoring of tacrolimus, mycophenolate and oral corticosteroids in adult kidney transplantation. The Complex Evolution of Kidney Transplantation: Pre-transplant Donor and Recipient Assessment, Transplant Surgery, Immunosuppression, High Risk Transplants and Management of Post Transplant Complications. (pp. 185-261) edited by Wai Hon Lim. New York, NY, USA: Nova Science Publisher.
2014
Conference Publication
Comparing utilisation of mycophenolate, tacrolimus, cyclosporin, sirolimus and everolimus in Australia and Northern Europe
Staatz, C. E., Gardiner, K. M. and Tett, S. E. (2014). Comparing utilisation of mycophenolate, tacrolimus, cyclosporin, sirolimus and everolimus in Australia and Northern Europe. Joint meeting of ASCEPT and Molecular Pharmacology of G protein-coupled receptors (MGPPCR), Melbourne, Australia, 7-11th December 2014.
2013
Journal Article
Effects of combinational CYP3A5 6986A>G polymorphism in graft liver and native intestine on the pharmacokinetics of tacrolimus in liver transplant patients: a meta-analysis
Buendia, Jefferson A., Bramuglia, Guillermo and Staatz, Christine E. (2013). Effects of combinational CYP3A5 6986A>G polymorphism in graft liver and native intestine on the pharmacokinetics of tacrolimus in liver transplant patients: a meta-analysis. Therapeutic Drug Monitoring, 36 (4), 442-447. doi: 10.1097/FTD.0000000000000032
2013
Journal Article
PharmGKB summary: cyclosporine and tacrolimus pathways
Barbarino, Julia M., Staatz, Christine E., Venkataramanan, Raman, Klein, Teri E. and Altman, Russ B. (2013). PharmGKB summary: cyclosporine and tacrolimus pathways. Pharmacogenetics and Genomics, 23 (10), 563-585. doi: 10.1097/FPC.0b013e328364db84
2013
Journal Article
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease
Abd Rahman, Azrin N., Tett, Susan E. and Staatz, Christine E. (2013). Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease. Clinical Pharmacokinetics, 52 (5), 303-331. doi: 10.1007/s40262-013-0039-8
2013
Journal Article
A differential impact of mycophenolic acid, prednisolone, and tacrolimus exposure on scd30 levels in adult kidney transplant recipients
Barraclough, Katherine A., Staatz, Christine E., Johnson, David W., Gillis, David, Lee, Katie J., McWhinney, Brett C., Ungerer, Jacobus P. J., Campbell, Scott B. and Isbel, Nicole M. (2013). A differential impact of mycophenolic acid, prednisolone, and tacrolimus exposure on scd30 levels in adult kidney transplant recipients. Therapeutic Drug Monitoring, 35 (2), 240-245. doi: 10.1097/FTD.0b013e31828286dd
2013
Journal Article
Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis
Hennig, Stefanie, Standing, Joseph F., Staatz, Christine E. and Thomson, Alison H. (2013). Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis. Clinical Pharmacokinetics, 52 (4), 289-301. doi: 10.1007/s40262-013-0036-y
2013
Conference Publication
Identification of continuous covariate relationships
Størset, Elisabet, Staatz, Christine, Hennig, Stefanie, Bergmann, Troels K. and Holford, Nick (2013). Identification of continuous covariate relationships. 15th Annual Population Approach Group Australia and New Zealand Meeting (PAGANZ 2013), Brisbane, QLD, Australia, 13-15 February 2013.
2013
Conference Publication
Effect of the CYP3A5 6986A > G Polymorphism on Tacrolimus Pharmacokinetics in Liver Transplant Recipients: A Meta-analysis
Buendia, J. A., Bramuglia, G. and Staatz, C. E. (2013). Effect of the CYP3A5 6986A > G Polymorphism on Tacrolimus Pharmacokinetics in Liver Transplant Recipients: A Meta-analysis. 13th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Salt Lake City Ut, 22-26 September 2013. Philadelphia, PA United States: Lippincott Williams and Wilkins. doi: 10.1097/FTD.0b013e3182a8ef2b
2013
Conference Publication
A population pharmacokinetic model of tacrolimus in adult kidney transplant recipients.
Bergmann, T. K., Hennig, S., Barraclough, K. A., Isbel, N. M. and Staatz, C. E. (2013). A population pharmacokinetic model of tacrolimus in adult kidney transplant recipients.. Annual meeting of the Danish Society of Pharmacology conference, Odense, Denmark, January 2013.
2013
Journal Article
Population Pharmacokinetics of Tacrolimus in Adult Kidney Transplant Patients: Impact of CYP3A5 Genotype on Starting Dose.
Bergman, Troels K., Hennig, Stefanie, Barraclough, Katherine A., Isbe,l Nicole M. and Staatz, Christine E. (2013). Population Pharmacokinetics of Tacrolimus in Adult Kidney Transplant Patients: Impact of CYP3A5 Genotype on Starting Dose.. Therapeutic Drug Monitoring, 36 (1), 62-70. doi: 10.1097/FTD.0b013e31829f1ab8
2013
Conference Publication
Usage and monitoring of intravenous tobramycin in cystic fibrosis in Australia and the United Kingdom
Paviour, Sophie, Hennig, Stefanie and Staatz, Christine (2013). Usage and monitoring of intravenous tobramycin in cystic fibrosis in Australia and the United Kingdom. 39th SHPA National Conference, Cairns, Australia, 19-22 September 2013.
2013
Conference Publication
Population pharmacokinetics of tacrolimus in adult kidney transplant recipients
Staatz, C. E., Bergmann, T. K., Barraclough, K. A., Isbel, N. M. and Hennig, S. (2013). Population pharmacokinetics of tacrolimus in adult kidney transplant recipients. Population Approach Group in Europe conference, Glasgow, Scotland, June 2013.
2013
Conference Publication
A review of population pharmacokinetic and pharmacodynamic studies of mycophenolate in Autoimmune Disease patients
Abu Rahman, A. N., Tett, S. E. and Staatz, C. E. (2013). A review of population pharmacokinetic and pharmacodynamic studies of mycophenolate in Autoimmune Disease patients. Population Approach Group in Australia and New Zealand conference, Brisbane, QLD, Australia, February 2013.
Funding
Current funding
Supervision
Availability
- Dr Christine Staatz is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Improving patient centred outcomes in kidney transplant recipients
Principal Advisor
Other advisors: Dr Andrew Mallett
-
Doctor Philosophy
Exploring free plasma tacrolimus and mycophenolic acid measurements and defining a therapeutic target range for therapeutic drug monitoring
Principal Advisor
Other advisors: Dr Meng-Wong Taing
-
Doctor Philosophy
To investigate the pharmacotherapy management of the bariatric surgery patient and the impact of the pharmacist in the multidisciplinary team
Principal Advisor
Other advisors: Dr Meng-Wong Taing
-
Doctor Philosophy
Establishing the Role of Metformin for Autosomal Dominant Polycystic Kidney Disease Management
Associate Advisor
Other advisors: Professor David Johnson, Professor Carmel Hawley, Associate Professor Andrea Viecelli, Dr Andrew Mallett
-
Doctor Philosophy
The IMPEDE-PKD Clinical Trial - Investigating the repurposing of metformin in ADPKD
Associate Advisor
Other advisors: Professor David Johnson, Professor Carmel Hawley, Dr Andrew Mallett, Associate Professor Andrea Viecelli
Completed supervision
-
2024
Doctor Philosophy
Improving patient centred outcomes in kidney transplant recipients
Principal Advisor
Other advisors: Dr Andrew Mallett
-
2023
Doctor Philosophy
Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Children: Once daily administration
Principal Advisor
-
2022
Doctor Philosophy
Optimising immunosuppressant medicines in elderly kidney transplant recipients
Principal Advisor
-
2021
Doctor Philosophy
Evaluating Prediction Methods for Estimating Tacrolimus, Mycophenolate and Prednisolone Exposure Following Adult Kidney Transplantation
Principal Advisor
Other advisors: Emeritus Professor Sue Tett
-
2016
Doctor Philosophy
Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
Principal Advisor
Other advisors: Emeritus Professor Sue Tett
-
2016
Doctor Philosophy
Optimizing beta-lactam antibiotic dosing in critically ill patients: Prolonged infusion versus intermittent bolus administration
Associate Advisor
Other advisors: Professor Jeffrey Lipman, Professor Jason Roberts
-
2012
Doctor Philosophy
Pharmacokinetic, Pharmacogenetic and Pharmacodynamic Monitoring of Immunosuppressive Therapy in Adult Kidney Transplant Recipients
Associate Advisor
-
2018
Doctor Philosophy
Optimising gentamicin therapy in paediatric oncology patients
Joint Principal Advisor
-
2017
Doctor Philosophy
The impact of increasing patient weight on the dosing of high-dose methotrexate chemotherapy in aggressive non-Hodgkin lymphoma
Joint Principal Advisor
Media
Enquiries
For media enquiries about Dr Christine Staatz's areas of expertise, story ideas and help finding experts, contact our Media team: